Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 6,210.00
-330.00 (-5.05%)
Aug 29, 2025, 9:40 AM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 301.15 billion as of August 28, 2025. Its market cap has increased by 57.59% in one year.
Market Cap
301.15B
Enterprise Value
219.23B
Revenue
5.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,210.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has increased from 238.64B to 301.15B, an increase of 26.19%. That is a compound annual growth rate of 1.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 278.58B | 124.07% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | 882.29B | -55.53% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.31T |
| Celltrion | 38.43T |
| ALTEOGEN | 23.41T |
| Yuhan | 8,738.55B |
| SK Biopharmaceuticals | 7,870.48B |
| Peptron | 7,327.02B |
| PharmaResearch | 7,210.42B |
| LigaChem Biosciences | 5,354.44B |